OnCore Login

Return to Trial Database

GYN10-149

A Phase I-II Clinical Trial of Pegylated Liposomal Doxorubicin (Doxil®) in Combination With BIBF 1120 in Patients With Ovarian Cancer: Hoosier Oncology Group GYN10-149

Status

Study Completed

Cancer Type(s)

Ovarian

Study Contact

Publications

Phase I trial of pegylated liposomal doxorubicin in combination with BIBF 1120 (nintedanib) in platinum-resistant ovarian cancer
  • MC deLeon, A Arnold, EC Rossi, J Case, C Johnson, Y Zeng, D Matei

Trial Locations

All sites in which the trial GYN10-149 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278